We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Dynavax Reports Phase 1a Safety and Immunogenicity Results for Universal Flu Vaccine

News   Dec 13, 2010

 
Dynavax Reports Phase 1a Safety and Immunogenicity Results for Universal Flu Vaccine
 
 
 

RELATED ARTICLES

Immune System Protein Helps Suppress HIV

News

A new study reveals the role of a protein that serves to block HIV gene expression once it has entered human cells.

READ MORE

Probiotic Consumption Impacts Breast Milk Composition

News

The complex sugars found in human breastmilk, long believed to be fixed in their composition, may change in women who are taking probiotics.

READ MORE

Making Resistant Melanomas Susceptible to Immunotherapy

News

A Ludwig Cancer Research study has uncovered a cellular mechanism by which melanomas that fail to respond to checkpoint blockade may be made susceptible to such immunotherapies.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE